Author:
Bors Sacha,Abler Daniel,Dietz Matthieu,Andrearczyk Vincent,Fageot Julien,Nicod-Lalonde Marie,Schaefer Niklaus,DeKemp Robert,Kamani Christel H.,Prior John O.,Depeursinge Adrien
Abstract
AbstractAssessing the individual risk of Major Adverse Cardiac Events (MACE) is of major importance as cardiovascular diseases remain the leading cause of death worldwide. Quantitative Myocardial Perfusion Imaging (MPI) parameters such as stress Myocardial Blood Flow (sMBF) or Myocardial Flow Reserve (MFR) constitutes the gold standard for prognosis assessment. We propose a systematic investigation of the value of Artificial Intelligence (AI) to leverage [$$^{82}$$
82
Rb] Silicon PhotoMultiplier (SiPM) PET MPI for MACE prediction. We establish a general pipeline for AI model validation to assess and compare the performance of global (i.e. average of the entire MPI signal), regional (17 segments), radiomics and Convolutional Neural Network (CNN) models leveraging various MPI signals on a dataset of 234 patients. Results showed that all regional AI models significantly outperformed the global model ($$p<0.001$$
p
<
0.001
), where the best AUC of 73.9% (CI 72.5–75.3) was obtained with a CNN model. A regional AI model based on MBF averages from 17 segments fed to a Logistic Regression (LR) constituted an excellent trade-off between model simplicity and performance, achieving an AUC of 73.4% (CI 72.3–74.7). A radiomics model based on intensity features revealed that the global average was the least important feature when compared to other aggregations of the MPI signal over the myocardium. We conclude that AI models can allow better personalized prognosis assessment for MACE.
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
CHUV Lundin Center for Neuro-oncology, Switzerland
Swiss Cancer Research Foundation
Hasler Stiftung
Publisher
Springer Science and Business Media LLC